With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Generation of a novel oncolytic virus for treatment of pediatric brain tumors.||The Ohio State University / Balveen Kaur, PhD||Young Investigator Grants||2007||Ohio|
|The Identification of Neuroblastoma Cancer Stem Cells.||Stanford University / Robert Cho||Young Investigator Grants||2007||California|
|Developing an accurate genetic model for rhabdomyosarcoma therapy||Children's Research Institute / Dawn Chandler, PhD||Young Investigator Grants||2007||District of Columbia|
|The Role of Inhibition of Apoptosis by C/EBPalpha and C/EBPalpha oncoproteins in AML.||The Johns Hopkins University School of Medicine / Ido Paz-Priel, MD||Young Investigator Grants||2007||Maryland|
|Research Institute at Nationwide Children's Hospital / Mary Beth Ross, MD/PhD||Young Investigator Grants||2006||Ohio|
|Mediators of Metastasis in Alveolar Rhabdomyosarcoma.||University of Texas Health Science Center at San Antonio / Koichi Nishijo, MD, PhD||Young Investigator Grants||2006||Texas|
|New Approaches to Neuroblastoma Therapy (NANT) Consortium||Children's Hospital Los Angeles / Robert Seeger, MD||Phase I/II Infrastructure Grants||2006||California|
|Pediatric Oncology Translational Research Program.||Vanderbilt University Medical Center / James Whitlock, MD||Phase I/II Infrastructure Grants||2006||Tennessee|
|Building a Texas-based center for neuroblastoma clinical research.||Baylor College of Medicine / Heidi Russell, MD||Phase I/II Infrastructure Grants||2006||Texas|
|Use sophisticated approaches to optimize the effectiveness of current chemotherapy agents, and to develop novel chemotherapy agents||Seattle Children's Hospital and Regional Medical Center / Julie Park, MD||Phase I/II Infrastructure Grants||2006||Washington|